Thursday 4 June 2020

BioLargo Discusses Clyraguard, BioLargo PFAS Treatment Technology Scale-up and Commercialization, and Progress of South Korean Joint Venture with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - June 4, 2020) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), developer of sustainable technologies and a full-service environmental engineering company with a focus on clean water, clean air, and advanced antimicrobial products. President & CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.
Jolly began by asking about the Company's subsidiary, Clyra Medical Technologies Inc., which recently launched a new product called Clyraguard. "This is a personal protection spray," explained Calvert. "It is hospital-grade, FDA-registered and cleared, and is 99.99% effective. This is an absolute winner," said Calvert.
"How big do you think this product can become?", asked Jolly. Calvert shared that Clyraguard has the potential to benefit a wide variety of people. "We know that it is the perfect product for a frontline healthcare worker," said Calvert, adding that the product is also suitable for individuals that are considered high-risk or are simply looking for protection against a number of pathogens. "We don't know of any product that matches the feature benefits of this product," said Calvert.
Calvert shared that Clyra has already begun selling the product, which is currently retailing at around $25 for a four-ounce bottle. "[Clyra is] building distribution as we speak, and adding team members to really help build that distribution. So, we think this is going to be a big blockbuster for the company."
Jolly then asked about the Company's patented CupriDyne® Clean product, and about the progress of their joint venture in South Korea. Calvert shared that the Company has finalized a joint venture with one of the leading waste water treatment groups in South Korea. "We got that transaction put together just a few months ago," said Calvert, discussing the tremendous potential of this agreement as the effects of the pandemic begin to subside.
"Where are we at with the PFAS solution?", asked Jolly, commenting on the Company's industrial water treatment technology aimed at eliminating per- and polyfluoroalkyl substances (PFAS) from water, called the BioLargo AEC. Calvert explained that the BioLargo AEC is a solution to the PFAS crisis which is both effective and affordable. "We'd like to be in commercial trials within the next 120 days," he continued, adding that the primary focus of this project is currently to produce a scaled-up version of the technology, which company management expects will be completed soon. Calvert explained that potential commercial trial clients are lining up.
To close the interview, Calvert expressed the potential of the Company's long list of technologies, which have continued to advance despite the current challenges of the pandemic. "We think that the future is right here before us," closed Calvert.
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at

About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to "make life better". We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment ( Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship ( Our industrial odor control division, Odor-No-More ( features CupriDyne Clean Industrial Odor Eliminator (, which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water ( develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and licensor to our subsidiary Clyra Medical (, which features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Name: Dennis P. Calvert
Phone: (888)-400-2863
Address: 14921 Chestnut St, Westminster CA, 92683
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
Stock Day Media
(602) 821-1102

No comments:

Post a Comment